HeartSciences Inc.(HSCS)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.0M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
HSCS Stock Analysis & AI Quality Score
AI stock analysis and institutional research for HeartSciences Inc. (HSCS), a Healthcare sector company. HSCS is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.0m in revenue. Based on the latest XBRL financial filings (Q3 2026), HeartSciences Inc. reports net income of $-2.0M, free cash flow of $-1.5M. Top institutional holders of HSCS by reported 13-F value include DRW Securities,, TFB Advisors, GEODE CAPITAL MANAGEMENT,, based on the most recent SEC filings. HSCS trades on the Nasdaq exchange and files with the SEC under CIK 1468492. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HSCS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HeartSciences Inc. directly from SEC EDGAR.
Revenue
Q3 2026
$0.00
Net Income
Q3 2026
$-2.0M
Free Cash Flow
Q3 2026
$-1.5M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-76.6% YoYNet Income
-32.7% YoYOperating Income
-32.5% YoYEPS (Diluted)
+50.2% YoYTotal Assets
-55.6% YoYOp. Cash Flow
-22.1% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $4.3K -76.6% | $18.6K +261.2% | $5.2K -64.2% | $14.4K | — |
| Net Income | $-8.8M -32.7% | $-6.6M -3.9% | $-6.4M -31.6% | $-4.8M | — |
| Operating Income | $-8.4M -32.5% | $-6.3M -3.2% | $-6.1M -29.8% | $-4.7M | — |
| EPS (Diluted) | $-4.67 +50.2% | $-9.37 +88.3% | $-80.00 -5417.2% | $-1.45 | — |
| Total Assets | $4.2M -55.6% | $9.5M +189.1% | $3.3M +57.3% | $2.1M | — |
| Operating Cash Flow | $-7.4M -22.1% | $-6.1M -5.1% | $-5.8M -58.4% | $-3.6M | — |
Get alerted when HSCS's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for HeartSciences Inc. including:
Top Institutional Holders of HSCS
DRW Securities, LLC
$192.2K76,450 shTFB Advisors LLC
$74.8K29,740 shGEODE CAPITAL MANAGEMENT, LLC
$71.2K28,938 shAstoria Strategic Wealth, Inc.
$47.6K18,927 shTradition Wealth Management, LLC
$42.3K16,819 shUBS Group AG
$16.3K6,476 shTower Research Capital LLC (TRC)
$5.2K2,051 shFederation des caisses Desjardins du Quebec
$1.8K700 shAdvisory Services Network, LLC
$696.00277 shOSAIC HOLDINGS, INC.
$125.0050 sh
| Fund | Value | Shares |
|---|---|---|
| DRW Securities, LLC | $192.2K | 76,450 |
| TFB Advisors LLC | $74.8K | 29,740 |
| GEODE CAPITAL MANAGEMENT, LLC | $71.2K | 28,938 |
| Astoria Strategic Wealth, Inc. | $47.6K | 18,927 |
| Tradition Wealth Management, LLC | $42.3K | 16,819 |
| UBS Group AG | $16.3K | 6,476 |
| Tower Research Capital LLC (TRC) | $5.2K | 2,051 |
| Federation des caisses Desjardins du Quebec | $1.8K | 700 |
| Advisory Services Network, LLC | $696.00 | 277 |
| OSAIC HOLDINGS, INC. | $125.00 | 50 |
More Healthcare Companies
View all Healthcare →Put HSCS on your watchlist
Track score changes the day HeartSciences Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is HSCS a good stock to buy?
13F Pro's AI-powered analysis of HeartSciences Inc. (HSCS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HSCS are available on the HSCS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own HSCS?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HSCS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of HeartSciences Inc.'s investment landscape.